Oxford Nanopore Technologies

And that's a wrap! Huge thank you to everyone who presented at, attended, or tuned in to NCM Boston. Couldn't make it? Catch up on talks in the virtual platform, or read up on what you missed in our latest blog. #nanoporeconf https://lnkd.in/eHp5Qdb4

#ElysION is the ultimate sample-to-answer, automated sequencing solution for researchers needing hands-free, simplified genomic workflows — from sample prep to data analysis. Whether you're focused on microbiology, clinical research, environmental studies, or food testing, ElysION transforms lab efficiency with ultra-rich nanopore sequencing data generation and minimal hands-on time. Benefits include: ~End-to-end workflows ~No genomic expertise required ~Optimised for diverse applications, from microbial isolate sequencing to RNA sequencing and metagenomics ~Cost-effective — reduce turnaround time and automate data analysis Join Tecan's webinar today at 4pm (CET) to discover the power of ElysION: https://lnkd.in/e_V9DzAT Or, find out more about more about ElysION here on our product page: https://lnkd.in/e6xSHYWi

Early and rapid detection of viral respiratory pathogens is vital in the fight against them, and genomic surveillance is an essential tool. In our upcoming webinar, Dr. Daniel Maloney will share how to perform whole genome amplification and characterisation of Respiratory Syncytial Virus (RSV), providing insight into the circulating diversity of RSV. Following this, Dr. Nick Gauthier will describe a rapid, end-to-end metagenomic #nanopore sequencing assay with for infection control and public health surveillance. Following this, Dr. Nick Gauthier will describe a rapid, end-to-end metagenomic #nanopore sequencing assay with potential for infection control and public health surveillance. Click the link to register: https://bit.ly/4f56xTY

Of all the RNAs, tRNA is the most abundant & diversely modified. Yet studying tRNA has been challenging. Read how a group of researchers successfully sequenced tRNA using direct RNA chemistry & compared the reproducibility of tRNA abundance metrics: https://bit.ly/46TvE9x

Rapid bacterial detection plays a vital role in food safety, clinical microbiology, and environmental monitoring. Traditionally, sequencing of the 16S ribosomal RNA (rRNA) gene by short-read sequencing has been used to classify and identify bacteria at various taxonomic levels. However, short reads cannot cover the full length of the 16S rRNA gene (~1,500 bp) — limiting the resolution for species-level identification. This blog showcases how long Oxford #Nanopore sequencing reads can overcome this challenge by spanning the full length of the 16S gene, enabling species-level identification and identifying species missed by legacy technologies. Learn more: https://bit.ly/4gZrfql

With no bioinformatics experience necessary, discover how you can analyse #nanopore sequencing data with #EPI2ME. The analysis platform simplifies data analysis using preconfigured workflows and detailed interactive reports. Learn more in our brochure: https://bit.ly/4ePpwlK

Amanda Pritchard, Chief Executive of NHS England, recently visited the Trust to see first-hand how genomic medicine is improving personalised care for patients with severe respiratory infections. The test, delivered through the Centre for Clinical Infection and Diagnostic Research (CIDR), involves using patients’ complete DNA, or genome, to guide healthcare decisions. It can identify what is causing an infection within seven hours and gives doctors faster and more accurate information about how to treat the patient, compared with existing methods. It was developed by scientists and clinicians at St Thomas’ Hospital in partnership with Synnovis and King’s College London, and is now being rolled out to 10 sites across the country. #DiagnosticResearch #GenomicMedicine

In collaboration with Jan Karlseder and Tobias Schmidt at the Salk Institute for Biological Studies, we developed Telo-seq, a method to enrich and sequence all telomeres within a sample using Oxford Nanopore Technologies long-read sequencing. The long-reads overcome the high sequence homology challenges with short-read technologies to capture enough subtelomeric sequences to distinguish between chromosome arms. Telo-seq applications include the evaluation of telomere-targeted therapeutics, underscoring the need for more rigorous telomere length assignments in diseases, aging, and development. Telo-seq will help resolve the effect of telomere sequence and structure on biological function. Thank you @NatureRevCancer for highlighting our tool! https://lnkd.in/gxsa6vnE

Biopharma quality controls (QC) are vital throughout the drug development pathway, yet current strategies require multiple, inefficient methods — adding complexity and delaying turnaround time. In this brochure learn how #nanopore technology is enabling the delivery of rapid and comprehensive QC tests that can replace multiple legacy assays for faster access to robust results. Read here https://bit.ly/4cRRKdY What you're missing matters. #WYMM

We’re pleased to share that we’re working with Oxford Nanopore Technologies (Oxford Nanopore) to bring to market an innovative, rapid HLA typing solution utilizing our AllType™ family of assays in combination with Oxford Nanopore’s real-time sequencing technology. When it comes to typing organ donors and recipients, time is of the essence. But today’s rapid solutions often trade resolution for speed. By utilizing Oxford Nanopore’s real-time, any-length read sequencing technology with our industry-leading HLA expertise, we aim to deliver high-resolution HLA typing in just a few hours, contributing to better patient-donor matching and improved outcomes for transplant recipients. “We’re excited to combine our 40-year history of innovation in the transplant diagnostics industry with Oxford Nanopore’s next generation sequencing technology to further enhance our end-to-end portfolio of transplant diagnostic solutions and enable our customers to make better and more timely organ matching decisions, with the ultimate aim of improving patients’ lives,” said Tina Liedtky, president, Transplant Diagnostics, Thermo Fisher Scientific. Sign up to be notified as soon as this new solution is available here: http://spr.ly/6041qtJuU